The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 13, 2021

Filed:

Jul. 13, 2017
Applicants:

Technion Research and Development Foundation Ltd., Haifa, IL;

Rambam Med-tech Ltd., Haifa, IL;

Inventors:

Izhak Kehat, Haifa, IL;

Alon Abend, Ramat Gan, IL;

Omer Shkedi, Haifa, IL;

Lilac Caspi, Aloney Abba, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61P 9/10 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/713 (2006.01); A61K 45/06 (2006.01); A61K 38/15 (2006.01); A61K 38/12 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/713 (2013.01); A61K 38/12 (2013.01); A61K 38/15 (2013.01); A61K 45/06 (2013.01); A61P 9/10 (2018.01); C12N 15/113 (2013.01); C12N 2310/14 (2013.01);
Abstract

A pharmaceutical composition and a method of treating, reducing or preventing vascular, cardiovascular arterial or valve calcification in a subject in need comprising administering to the subject an effective amount of an agent that prevents or reduces the expression of HDAC4, an agent that modulates the location of HDAC4, an agent that binds to HDAC4 or an inhibitor of HDAC4 or any combination thereof is provided. In some embodiments, there is provided a pharmaceutical composition comprising: an agent that prevents or reduces the expression of HDAC4, an agent that modulates the location of HDAC4, an agent that binds to HDAC4 or an inhibitor of HDAC4 or any combination thereof; an agent that prevents or reduces the expression of SIK or is an inhibitor of SIK; and/or an agent that prevents or reduces the expression of ENIGMA (Pdlim7) or is an inhibitor of ENIGMA.


Find Patent Forward Citations

Loading…